A NEW APPROACH TOWARD TREATMENT OF HYPEROPIC RESIDUAL REFRACTION ERROR AND PRESBYOPIA AFTER CATARACT SURGERY

To investigate the effect of fresh corneal myopic lenticule implantation as an allogenic implant that will be taken from myopic patients to implant on pseudophakic patients with residual hypermetropic refraction using VisuMax Femtosecond Laser-Smile module surgery with primary objective to assess(increase) visual acuity.

Eye Hospital,Pristina,Kosovo.

84 eyes of 42 patients (aged 46 to 67 years).
Residual hyperopia between +0.75 and +3.25 D
Before SMILE, YAG-laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, 
Astigmatism between +0.50 and +1.75 D. 
In pseudophakic patients with hyperopic astigmatism residual refraction, corneal topography-guided intrastromal fresh myopic lenticule implantation should be performed and the lenticule was placed according to the low K value.

The UDVA increased from 0.67 ± 0.07 logMAR preoperatively to 0.08 ± 0.02 logMAR 12 months postoperatively (p < 0.001).

UNVA had an increase in J 2 one year after preop J 8. UNVA (35cm) was increased that, preop from 7J [5J to 8J] to 2 J [1J to 2J] 1-year postop, it was statistically significant (p<0.001).

SMILE module is a reliable method for treating hyperopic residual refraction and presbyopia after trifocal IOL implantation. Similar studies should increase in the future because we believe that Smile is the most reliable, most straightforward, and uncomplicated treatment method among the options, which increases both satisfaction and vision of the patient rapidly.

ClinicalTrials.gov Identifier: NCT04692012